REQUEST A DEMO
Total
USD $0.00
Search more companies

Fraglos Lab S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fraglos Lab S.A.S. Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Fraglos Lab S.A.S. is an enterprise located in Colombia, with the main office in Tocancipa. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on October 28, 2021. The total number of employees is currently 22 (2026). From the latest financial highlights, Fraglos Lab S.A.S. reported a net sales revenue increase of 140.5% in 2025. Fraglos Lab S.A.S.’s net profit margin increased by 12.24% in 2025.

Headquarters
Km 2 Via Briceno Zipaquira Par Industrial Tibitoc Bg 63
Tocancipa; Cundinamarca;

Contact Details: Purchase the Fraglos Lab S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Fraglos Lab S.A.S. report to view the information.
Financial Auditors:
Purchase the Fraglos Lab S.A.S. report to view the information.
Incorporation Date:
October 28, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Fraglos Lab S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
140.5%
Total Operating Revenue
140.5%
Operating Profit
386.9%
Net Profit/Loss for the Period
430.69%
Total Assets
0%
Total Equity
0%
Operating Profit Margin
12.29%
Net Profit Margin
12.24%
Return on Equity (ROE)
3521.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?